A11- Notice of Intent to Sole Source.pdf
PDF 138 KB Posted
- Attached to
- CDC DFWED NARST Sensititre Supplies
- Solicitation number
- Not on record
About this file
This document is a Notice of Intent to Sole Source issued by the Centers for Disease Control and Prevention (CDC) to award a sole source firm fixed price contract to Thermo Fisher Scientific for the purchase of testing supplies, equipment, and service agreement provisions for the National Antimicrobial Resistance Monitoring System (NARMS) surveillance program. The CDC intends to use the Sensititre broth microdilution testing method, which is proprietary to Thermo Fisher Scientific and required for the continuity of the standardized NARMS surveillance conducted since 1996. The CDC states that no other providers can satisfy the agency's requirements, as the Sensititre method is necessary for timely, integrated surveillance and trend analysis. Interested parties may identify their interest and capability to respond to the requirement or submit proposals by 12:00 PM EST on November 21, 2024. However, the government has sole discretion in determining whether to conduct a competitive procurement based on the responses received.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| A13- Sole Source Justification_V2_ SL signed 6 Nov 24_Redacted.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to ThermoFisher Scientific for the purchase of the following:
Only one responsible source and no other providers will satisfy agency requirements, as surveillance for antimicrobial resistance among enteric bacteria in the United States is conducted by a tri-agency partnership among CDC, FDA and USDA, through the National Antimicrobial Resistance Monitoring System (NARMS), and the method required is Sensititre™ broth microdilution testing. The testing supplies, equipment and service agreement provisions are proprietary and only provided by ThermoFisher Scientific. Continuity of the surveillance that has been performed in this standardized way since 1996 is very important. Other non-Sensititre antimicrobial susceptibility testing methods would require extensive validation and equivalency studies, and switching to a different method would undermine our ability to do timely, integrated surveillance and trend analysis, major goals of our surveillance program, and undermine our ability to achieve our mission in comparing data collected from humans with historical data collected by FDA and USDA on retail
This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within 15 days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.
Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist Ashley Williams at dal3@cdc.gov by 12:00 PM EST on November 21, 2024.
File details come from the government source that posted it. Updated .